AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US
AstraZeneca PLC Ordinary Shares (AZN)
Last astrazeneca plc ordinary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Business Wire
US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $18 million to date WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has proudly awarded $3.4 million to nonprofit organizations in the US through its Accelerate Change Together (ACT) on Health Equity initiative. This effort aims to support programming that prioritizes the social, cultural and linguistic needs of communities that have experienced barriers to care and opportunity.During its fifth year, AstraZeneca’s ACT on Health Equity initiative will fund 47 nonprofit programs whose missions support the goal of advancing health equity and focus on healthcare access, nutrition, lung health, and eliminating barriers that lead to a higher incidence of preventable conditions.Mohit Manrao, SVP, Head of US Oncology and President, AstraZeneca Foundation, said: “At AstraZeneca, we believe advancing health equity is fundamental to building a healthier society. Through our US AC
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC Ordinary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca results: FY and Q4 2025Business Wire
- AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- Shell chief exec to become one of FTSE's best paid bosses [Yahoo! Finance]Yahoo! Finance
- Why pharma manufacturers are still investing in Europe [Yahoo! Finance]Yahoo! Finance
- IonQ to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 2/10/26 - Form 6-K
- 2/3/26 - Form S-8
- 2/3/26 - Form 6-K
- AZN's page on the SEC website